Excess circulating iron is stored in the liver, and requires reduction of non-Tf-bound iron (NTBI) and transferrin (Tf) iron at the plasma membrane and endosomes, respectively, by ferrireductase (FR) proteins for transport across biological membranes through divalent metal transporters. Here, we report that prion protein (PrP indicate that PrP C promotes, and possibly regulates, the uptake of NTBI through DMT1 and Zip14 via its FR activity. Implications of these observations for neuronal iron homeostasis under physiological and pathological conditions are discussed.
t r a c t
Excess circulating iron is stored in the liver, and requires reduction of non-Tf-bound iron (NTBI) and transferrin (Tf) iron at the plasma membrane and endosomes, respectively, by ferrireductase (FR) proteins for transport across biological membranes through divalent metal transporters. Here, we report that prion protein (PrP C ), a ubiquitously expressed glycoprotein most abundant on neuronal cells, functions as a FR partner for divalent-metal transporter-1 (DMT1) and ZIP14. Thus, absence of PrP C in
PrP-knock-out (PrP -/-) mice resulted in markedly reduced liver iron stores, a deficiency that was not corrected by chronic or acute administration of iron by the oral or intraperitoneal routes. Likewise, preferential radiolabeling of circulating NTBI with 59 Fe revealed significantly reduced uptake and storage of NTBI by the liver of PrP -/-mice relative to matched PrP þ / þ controls. However, uptake, storage, and utilization of ferritin-bound iron that does not require reduction for uptake were increased in PrP indicate that PrP C promotes, and possibly regulates, the uptake of NTBI through DMT1 and Zip14 via its FR activity. Implications of these observations for neuronal iron homeostasis under physiological and pathological conditions are discussed. & 2015 Elsevier Inc. All rights reserved.
Introduction
Cells require iron for vital metabolic processes, but excess iron is cytotoxic due to its ability to participate in Fenton chemistry [1] . Iron homeostasis is therefore regulated at the systemic, organelle, and cellular levels by the coordinated action of iron uptake, transport, and storage proteins, which are themselves governed by iron regulatory proteins 1 and 2 as well as additional mechanisms [2] [3] [4] . Systemic iron homeostasis is maintained mainly by regulating uptake from the duodenum by the peptide hormone hepcidin released by hepatocytes in response to circulating iron [5, 6] . Most of the absorbed iron binds tightly to plasma transferrin (Tf), and the rest circulates as nonTf-bound iron (NTBI) in association with small molecular weight compounds. Normally, 30-40% of plasma Tf is saturated with iron, leaving significant buffering capacity for excess iron that may accumulate in pathological conditions. Additional protection is provided by hepatocytes that can internalize and store large quantities of iron before signs of hepatotoxicity appear [7, 8] .
Tf iron and NTBI exist in the relatively inert ferric form (Fe 3 þ ), through divalent metal transporters to the cytosol. NTBI, on the other hand, is reduced at the plasma membrane before transport, though recent reports indicate uptake and transport from the endosomes as well [7, 8, 10, 11] . Known FR proteins that function optimally at low pH of the endosomes include the Steap family of proteins, in particular Steap3 that plays a vital role in iron uptake by hematopoietic cells [12] . A prominent plasma membrane FR is duodenal cytochrome b (Dcytb) that reduces nonheme Fe 3 þ in the duodenum to Fe 2 þ for uptake by duodenal epithelial cells [13, 14] . The FR activity of Steap3 and Dcytb is coupled with the divalent metal transporter-1 (DMT1) that transports reduced iron across the lipid bilayer [15] . Recently, the ZIP family of divalent metal transporters has been described that functions at the plasma membrane and in late endosomes [16, 17] . Transported Fe 2 þ joins the cytosolic labile iron pool (LIP), is oxidized by ferritin and stored in its shell, or exported by the coupled action of a ferroxidase such as ceruloplasmin or hephaestin and the iron export protein ferroportin [3, 7, 18] . Recent reports indicate that prion protein (PrP C ), a mainly neuronal protein implicated in the pathogenesis of prion disorders, promotes cellular iron uptake by functioning as a FR [19] [20] [21] . In neuroblastoma cells, PrP C exhibits FR activity on the plasma membrane, and requires the N-terminal octapeptide repeat region for this activity [19] . Likewise, PrP C promotes retrieval of iron from the glomerular filtrate via its FR activity, and increases transcellular transport of NTBI from the apical to the basolateral domain of kidney proximal tubule epithelial cells [22] . Deletion of the Nterminal octapeptide repeat region abolishes this function, implicating the FR activity of PrP C in kidney iron uptake [22] . However, the metal transporter(s) involved in PrP C -associated iron uptake and transport are not known. Since liver is the principal organ that stores excess circulating iron, we used a combination of PrPknock-out (PrP -/-) transgenic mouse models and HepG2 cells expressing exogenous PrP C to explore the significance of FR activity of PrP C and associated divalent metal transporters in hepatic iron uptake. Here, we report that PrP C promotes the uptake of Fe 3 þ iron by hepatocytes through divalent metal transports ZIP14 and DMT1.
Materials and methods

Animals and ethics statement
Wild-type (PrP þ / þ ) and PrP-knock-out mice (PrP À / À ) [23] were originally obtained from George Carlson and bred on the FVB/NJ background for more than 10 years at the Animal Resource Center (ARC) at Case Western Reserve University (CWRU). Animal protocols and procedures were approved by the IACUC committee at CWRU.
Materials and cell culture
HepG2 cells (ATCC) were cultured in high glucose DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37 1C in a humidified atmosphere containing 5% CO 2 . Plasmid encoding DMT1-GFP (-IRE) was from Jerry Kaplan (University of Utah). PrP C and PrP C-GFP constructs were prepared by ligating cDNA from previously reported constructs [24] in modified PiggyBac vectors (System Biosciences, Mountainview, CA). HepG2 cells were cotransfected with the PiggyBac vectors and a transposaseexpression vector using Lipofectamine LTX (Invitrogen, Carlsbad, CA), and mixed cultures of $30 stable clones selected with Blasticidin-S were used for all experiments to avoid clonal artifacts. PrP antibody specific for residues 109-112 (3F4) was from Signet Laboratories (Dedham, MA). The specificity of anti-C antibody against C-terminal residues of human PrP (anti-C) has been described previously [25] . Antibodies specific to ferritin and Fe-ferritin (purified from mouse liver) [27] containing 11 mg of total iron were injected intraperitoneally (ip). (3) Unlabeled ferric-ammonium citrate (FAC, 70 mg/22 g body weight) was injected ip followed by 59 Fe-citrate after 30 min by the same route [28] . A parallel set of animals received 59 Fe-citrate without prior injection of FAC. At the indicated times, animals were euthanized and processed as described [20, 29] . Liver homogenates and lysed RBCs were resolved by SDS-PAGE and transferred proteins were probed with specific antibodies by Western blotting, or resolved by native PAGE and subjected to autoradiography [20, 29] . Serum iron, tissue nonheme iron, and iron content of purified ferritin was quantified by the iron estimation kit (Stanbio Laboratory, Boerne, TX). Serum ferritin was measured using an ELISA assay (Abcam) [20, 29] .
Iron uptake in vitro
HepG2 cells stably expressing vector or PrP C were exposed to
and expression of PrP C and ferritin was evaluated by Western blotting. Short-term experiments were conducted in RPMI medium lacking iron and transferrin. To assess the role of ZIP proteins and DMT1 in PrP C -mediated iron uptake, stable clones of vector and PrP C -expressing cells were cotransfected with ZIP8-GFP, ZIP14-GFP, or DMT1-GFP, and cultured for 48 h to allow protein expression. Transfection efficiency was evaluated by flow cytometry, and lysates were processed for Western blotting as above.
Immunostaining
Monolayers of HepG2 cells expressing PrP C-GFP were incubated with WGA-Alexa Fluor-594 (1:200) on ice for 30 min, washed, fixed with 4% paraformaldehyde, and stained with Hoechst 33342 (0.5 ng/ml) to visualize the nuclei. Mild fixation was necessary to preserve the GFP signal. Images were captured by confocal microscopy.
Results
Uptake and storage of iron by the liver are impaired in PrP
Previous reports indicate a phenotype of iron deficiency in transgenic mice carrying a deletion in PRNP, the gene encoding PrP [23] , and rescue of this phenotype by inserting PRNP in the PrP -/-background [20] . To evaluate whether the underlying cause is reduced availability or impaired uptake, storage, and utilization of circulating iron, age-and sex-matched PrP þ / þ and PrP -/-mice were fed regular chow or supplemented with 200 mg of carbonyl iron daily for 1 month [26] . Absorption from the duodenum and storage by the liver were assessed by quantifying levels of serum iron and ferritin, liver nonheme iron, and expression of liver tissue ferritin, the principal iron storage protein of hepatocytes and reticuloendothelial cells ( Fig. 1 ). Serum iron was significantly lower in PrP -/-mice on normal chow relative to matched controls, but approached control levels when supplemented with excess carbonyl iron (Fig. 1A) . However, serum ferritin remained significantly lower in PrP -/-samples despite normal serum iron, indicating a deficiency in iron storage (Fig. 1B) . Liver stores of nonheme iron and ferritin expression were reduced in PrP -/-mice, and remained significantly lower than matched controls even after administration of excess iron ( Fig. 1C -E). It is notable that despite exposure to excess iron, expression of liver ferritin in PrP -/-mice remained significantly lower than PrP þ / þ controls on normal chow (Fig. 1E ).
These results suggest that the principal cause of iron deficiency in PrP -/-mice is impaired hepatic uptake and storage of circulating iron rather than defective duodenal absorption.
PrP C promotes uptake of Tf iron and NTBI by the liver
Since orally introduced carbonyl iron circulates primarily as Tf iron and NTBI that require reduction of Fe 3 þ to Fe 2 þ before hepatic uptake [3, 8, 9] , we considered the possibility that the recently described FR activity of PrP C on cell models was necessary for the uptake of iron from these sources [19] . Thus, equal amounts of 59 Ferric-citrate were injected intraperitoneally in age-and sex- Fe by the spleen and femur, organs that utilize mainly Tf iron for hematopoiesis, was quantified at the indicated time points. As expected, a spike in the uptake of 59 Fe by newly synthesized red blood cells was noted after 24 h in both mouse lines. However, the counts in PrP -/-samples were significantly lower relative to matched PrP þ / þ controls ( Fig. 2A and B) .
To evaluate whether PrP C influences the uptake of NTBI, a circulating pool of NTBI in PrP þ / þ and PrP -/-mice was radiolabeled by saturating plasma Tf with excess unlabeled FAC, followed 30 min later by intraperitoneal injection of 59
Fe-citrate essentially as described [28] . The mice were euthanized after 6 h, and uptake of 59 Fe-NTBI by the liver and pancreas, the principal organs that store and utilize NTBI, respectively, was quantified.
Fractionation of equal aliquots of plasma from untreated (-FAC) and þFAC treated mice on native PAGE followed by autoradiography confirmed $90% inhibition of 59 Fe-labeling of plasma Tf in the latter (Fig. 2C, Fe-NTBI in the absence of PrP C .
These results suggest that PrP C promotes the uptake of both Tf iron and NTBI, and other iron-modulating proteins are unable to compensate fully for its absence. Fe counts were introduced intraperitoneally in PrP þ / þ and PrP -/-mice, and uptake of 59 Fe by the liver was quantified at the indicated times (Fig. 3) .
59
Fe counts in the blood and remaining carcass were quantified to eliminate error due to nonspecific phagocytosis of 59 Fe-ferritin in the peritoneal cavity.
Surprisingly, uptake of 59
Fe from ferritin was significantly higher in PrP -/-samples relative to PrP þ / þ controls at all the time points tested (Fig. 3 A) . However, uptake of 59 Fe from citrate that is likely to associate with plasma Tf and NTBI was significantly lower in PrP -/-mice (Fig. 3B) . Fe-ferritin, and much lower levels in both mouse lines exposed to 59 Fe-citrate (Fig. 3C, lanes 2-5) . Western blotting of the same samples for actin confirmed that the differences were not an artifact of sample loading.
To evaluate whether the stored 59 Fe in liver ferritin was used for hemoglobin synthesis, the predominant consumer of systemic iron, lysates prepared from 11 day washed RBCs were fractionated by native PAGE followed by autoradiography. The signal from 59 FeHb was much stronger in samples from PrP -/-mice exposed to 59 Fe-ferritin relative to matched PrP þ / þ controls, and from mice exposed to 59 Fe-citrate (Fig. 3D, lanes 2-5, arrowhead) .
Together, the above observations demonstrate that absence of PrP C limits hepatic uptake of circulating Tf iron and NTBI that require reduction to Fe 2 þ . Uptake of iron from ferritin that does not require reduction and metabolic processes subsequent to iron uptake, i.e., storage in liver ferritin, and utilization for hemoglobin synthesis are not affected by the absence of PrP C
. Surprisingly, mRNA levels of liver hepcidin, the master regulator of systemic iron homeostasis, did not show a significant difference between PrP -/-samples and matched PrP þ / þ controls. However, analysis of the same samples for additional iron-modulating proteins revealed significant upregulation of mRNA for divalent metal transporters ZIP8 and ZIP14, probably as a response to the iron deficiency in these mice (supplemental Fig. 1 ).
PrP C promotes NTBI uptake via ZIP14 and DMT1
To determine whether the FR activity of PrP C is coupled with iron uptake through specific metal transporters, HepG2 cells, a well-characterized hepatoma cell line, was used. Expression of a fusion construct of PrP C and green-fluorescent protein (PrP C-GFP ) [24] revealed expression on the plasma membrane, colocalizing with wheat-germ agglutinin (WGA) that binds to apical and basolateral surface glycoproteins on cultured HepG2 cells (Fig. 4 , panels 1-3) [31] . Before proceeding with the identification of PrP (Fig. 5A) . Expression of PrP C induced 2.7-fold upregulation of intracellular ferritin, indicating increased uptake of iron from the medium (Fig. 5A, lanes 1 vs 4) . Notably, exposure to Fe Tf iron and NTBI from the medium due to its FR activity. Subsequently, stable HepG2-vec and HepG2-PrP C cells were cotransfected with GFP-tagged ZIP8, ZIP14, or DMT1, and uptake of iron from complete medium (with no added iron) was quantified after 24 h as a function of ferritin upregulation. Expression of ZIP8, ZIP14, or DMT1 in HepG2-vec cells caused $ 3.2-fold upregulation of ferritin relative to controls, consistent with the iron transport function of these proteins (Fig. 5C, lane 1 vs 2-4, Fig. 5D ). However, coexpression of PrP C with ZIP8, ZIP14, or DMT1 induced a further upregulation of ferritin by 0.8-, 2.8-, and 2.6-fold, respectively, indicating that PrP C enhances iron uptake via these transporters, mainly ZIP14 and DMT1 (Fig. 5C, lanes 2-4 vs 6-8; Fig. 5D ). Notably, a significant decrease in PrP C expression accompanied coexpression of the iron transporter, particularly ZIP14 and DMT1. The decrease was specific to 3F4-reactive full-length PrP C , including the unglycosylated (27 kDa) and various glycoforms migrating between 30 and 37kDa (Fig. 5C, upper panel; Fig. 5E ). On the other hand, anti-C reactive PrP C forms that include N-terminally truncated unglycosylated (18 kDa) and glycosylated forms (18-30 kDa) in addition to full-length PrP C showed a corresponding increase (Fig. 5C, lower panel, lanes 7 and 8) . A darker exposure revealed upregulation and cleavage of endogenous PrP C in
HepG2-vec cells in the presence of ZIP14 and DMT1 (lower panel, darker exposure, lanes 3 and 4). Since PrP C undergoes physiological recycling from the plasma membrane and is cleaved at residues 111/112 during this process that eliminates the epitope for 3F4 (Fig. 5E ) [25] , it is likely that expression of ZIP14 and DMT1 upregulates recycling, or triggers cleavage of PrP C by an independent process.
Discussion
This report demonstrates that PrP C promotes uptake of NTBI and, to a lesser extent, Tf iron by providing FR activity necessary for the transport of ferric iron through divalent metal transporters ZIP14 and DMT1. This explains reduced hepatic iron stores of PrP -/-mice despite chronic iron supplementation, and enhanced uptake of ferric iron by HepG2 cells expressing exogenous PrP C .
Coexpression of PrP C with ZIP14 and DMT1 augments ferric iron uptake further, suggesting that PrP C functions as a FR partner for these transporters. In contrast, PrP C does not influence hepatic uptake and storage or utilization of ferritin-bound iron in vivo, or of iron ascorbate (Fe 2 þ ) by HepG2 cells in vitro, sources that do not require reduction of associated iron for uptake. These observations underscore the functional significance of PrP C as a FR, and the inability of other FR proteins to compensate fully for its absence. As reported previously [20] and expanded here, absence of PrP C results in systemic iron deficiency in PrP -/-mice as evidenced by significantly lower levels of serum iron, serum ferritin, liver nonheme iron, and liver ferritin relative to PrP þ / þ controls. Although chronic exposure to excess oral iron restored serum iron in PrP -/-mice to control levels, serum ferritin, liver nonheme iron, and liver ferritin remained significantly lower than iron-supplemented PrP
mice, suggesting impaired hepatic uptake and storage of iron as the principal cause of iron deficiency, not insufficient absorption from the duodenum. It is notable that impairment of hepatic iron uptake in PrP -/-mice is specific to NTBI and Tf iron that require reduction to the ferrous form for transport through divalent metal transporters [7, 9] . Uptake of Fe-Tf by the spleen and bone marrow, main hematopoietic organs that utilize Tf-bound iron, and Fe-NTBI by the liver and pancreas, principal organs that store and utilize NTBI, was significantly lower in PrP -/-mice relative to PrP þ / þ controls, despite systemic iron overload [28] . On the other hand, uptake, storage, and utilization of 59 Fe from iron-loaded ferritin that utilizes receptormediated uptake pathway [30] were increased in PrP -/-mice, highlighting the iron deficiency of these mice, and implicating PrP C in the uptake of ferric iron, not ferritin iron that is stored and used effectively in its absence. It is likely that the relatively mild iron deficiency in PrP -/-mice is due to the participation of PrP C in the uptake of mainly NTBI from the plasma membrane, not Tf iron that can utilize alternative FR proteins such as Steap3 in late endosomes. Consistent with this assumption, transcription of liver hepcidin, the master regulator of systemic iron homeostasis, was not altered in PrP -/-mice, though ZIP8 and ZIP14 showed significant upregulation (supplemental Fig. 1 , a physiological process that increases the proportion of N-terminally cleaved, Cterminal fragment of PrP C relative to the full-length form [25] . Since PrP C is expressed abundantly on neurons, it possibly functions as a FR partner for ZIP14 and DMT1 on the neuronal plasma membrane and endosomes, facilitating the uptake of NTBI and Tf iron by these cells. Concomitant cleavage of the N-terminus necessary for its FR activity is likely to regulate iron uptake, a phenomenon unique to PrP C and absent in other FR proteins such as Dcytb and Steap3 abundant on the plasma membrane and endosomes, respectively, of specific cell types (Fig. 5F) . A detailed understanding of the relationship between iron transport and endoproteolytic cleavage of PrP C is required for defining the contribution of PrP C to cellular iron metabolism.
Interestingly, PrP and the Zip family of proteins share an evolutionary link [33, 34] , and certain members of the Zip family are expressed in close proximity with PrP C at the plasma membrane [35] and are altered during prion infection [36] . ZIP14 is most abundant in the liver, pancreas, and heart and, like PrP C , is localized at the plasma membrane where it mediates the uptake of NTBI [16, 17, 37] . Recent reports indicate localization of ZIP14 in late endosomes and lysosomes in addition to the plasma membrane, suggestive of a role in the transport of Tf iron across the endosomal membrane [38] . ZIP8, on the other hand, is most abundant in the lung, testis, and kidney [39] . Impaired uptake of 59 Fe-NTBI by the liver and pancreas of PrP -/-mice therefore suggests that PrP C is the principal FR partner for ZIP14 on the plasma membrane of these organs. Although physical interaction of PrP C with the metal transporters is not necessary for the coupled reduction and transport of Fe 3 þ iron, limited colocalization of PrP C with ZIP14 was evident in HepG2 cells by confocal microscopy (unpublished observations).
In conclusion, this report provides convincing evidence that PrP C functions as a FR partner for ZIP14 and DMT1, and possibly regulates the uptake of NTBI and Tf iron by shedding its Nterminal FR domain during recycling from the plasma membrane. Since DMT1 and ZIP14 mediate the transport of other cations including copper and zinc, aggregation of PrP C to the diseaseassociated PrP-scrapie form during prion disease pathogenesis is likely to alter the homeostasis of other metals in addition to the reported effect on brain iron homeostasis [29, 40] . In addition, these observations have significant implications for Alzheimer's disease where brain metal imbalance is a prominent feature, and PrP is believed to play an important pathogenic role [41] [42] [43] [44] .
